This is also the phase where people start receiving comments from others
Additional Clinical Findings Worth Noting Beyond the headline studies, several smaller investigations provide supporting evidence
Good communication
Last reviewed: June 17, 2026 Last updated: June 17, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Instead, clinicians should acknowledge this risk and consider individualized risk-benefit strategies when prescribing GLP-1 RAs, particularly for patients with pre-existing ocular manifestations and must inform patients regarding possible ocular hazards while advocating for regular retinal examinations and assessments of visual acuity
PlexusDx patients receive detailed storage instructions with every shipment to ensure their medication remains safe and fully active throughout their treatment cycle